Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ABVC BIOPHARMA, INC. (ABVC)

ABVC BioPharma postpones BioKey share distribution, no new date set

Neutral Impact 3 of 5 shareholder Written later

ABVC BioPharma said on August 3, 2026 that it has postponed the previously announced distribution of BioKey (Cayman), Inc. ordinary shares, which had been scheduled for the same day. The company needs more time to complete administrative, regulatory and tax-related matters, and it is coordinating with Nasdaq, DTC and its transfer agent on revised mechanics and new dates.

Key points

  • Distribution scheduled for August 3, 2026 has been postponed; no new date has been set
  • Record date is unchanged and the distribution ratio remains 0.169464 BioKey ordinary shares per ABVC common share
  • The previously announced ex-dividend date no longer applies and will be revised; the company will announce the new dates once finalized

The filing

CompanyABVC BIOPHARMA, INC. (ABVC)
Form8-K, current report
Filed with the SECAug 3, 2026, 9:12 PM ET
Accession number0001213900-26-084846

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.